NCT01644955View on ClinicalTrials.gov

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 11, 2012

Primary Completion Date

December 8, 2017

Study Completion Date

December 8, 2017

Conditions
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaRecurrent Adult Brain Tumor
Interventions
DRUG

carboplatin

Carboplatin in a volume of 54 ml will be administered intracerebrally by convection enhanced delivery

PROCEDURE

Surgery

Patients will undergo surgery, which includes tumor resection and catheter placement, in the operating room.

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

James Elder

OTHER

NCT01644955 - Carboplatin in Treating Patients With Recurrent High-Grade Gliomas | Biotech Hunter | Biotech Hunter